Your session is about to expire
Lexapro vs Cymbalta
Introduction
For patients struggling with major depressive disorder (MDD), generalized anxiety disorder (GAD) or other types of psychological disorders, certain drugs that modify the levels of chemicals in the brain, known as neurotransmitters, can aid in managing symptoms and enhancing mood stability. Lexapro and Cymbalta are two such medications often prescribed for these conditions. Each influences different neurotransmitters within the brain, but both convey mood-stabilizing effects to patients suffering from depression or anxiety. Lexapro is classified as a selective serotonin reuptake inhibitor (SSRI), mainly impacting levels of serotonin. In contrast, Cymbalta falls under the category of a serotonin-norepinephrine reuptake inhibitor (SNRI), affecting both norepinephrine and serotonin levels.
Lexapro vs Cymbalta Side By Side
| Attribute | Lexapro | Cymbalta |
|---|---|---|
| Brand Name | Lexapro | Cymbalta |
| Contraindications | Should not be taken with or within 2 weeks of MAO inhibitors | Should not be taken with or within 5 days of MAO inhibitors |
| Cost | Brand: $356 for 30 tablets (10 mg), Generic: $0.60 - $1.50 per day | Brand: $249 for 30 capsules (20 mg), Generic: $0.15-$2 per day |
| Generic Name | Escitalopram | Duloxetine |
| Most Serious Side Effect | Increased thoughts about suicide or self-harm, particularly in people under 25 during the initial phases of treatment | Liver problems, signs of allergic reaction, and increased risk of suicidal thoughts |
| Severe Drug Interactions | MAO inhibitors due to the risk of serotonin syndrome | MAO inhibitors due to the risk of serotonin syndrome |
| Typical Dose | 10-20 mg/day | 30–60 mg/day, up to 120 mg/day |
What is Lexapro?
Escitalopram (the generic name for Lexapro) is a selective serotonin reuptake inhibitor (SSRI), while Duloxetine (the generic name for Cymbalta) falls into the category of serotonin and norepinephrine reuptake inhibitors (SNRIs). Both were significant advancements over the first class of antidepressant drugs, tricyclic antidepressants. Escitalopram was approved by the FDA in 2002 and works primarily by enhancing levels of free serotonin—like Prozac—by preventing it from being reabsorbed. It's prescribed to treat various forms of depression as well as generalized anxiety disorder.
On the other hand, Duloxetine, approved in 2004, affects both serotonin and norepinephrine neurotransmitters, aiming to balance their levels within the brain. It's used not only for treating different types of depression but also diabetic peripheral neuropathic pain, fibromyalgia and chronic musculoskeletal pain. While Escitalopram has a more targeted influence on serotonin with fewer side effects overall due to its lesser effect on other neurotransmitters like dopamine or norepinephrine; Duloxetine has broader effects which can result in additional benefits but potentially more side effects.
What conditions is Lexapro approved to treat?
Lexapro is approved for the treatment of several mental health conditions:
- Major depressive disorder (MDD), also known as unipolar depression
- Generalized anxiety disorder (GAD)
On the other hand, Cymbalta has a broader range of approved uses:
- Major depressive disorder (MDD)
- Generalized anxiety disorder (GAD)
- Diabetic peripheral neuropathic pain
- Fibromyalgia
- Chronic musculoskeletal pain
How does Lexapro help with these illnesses?
Lexapro is effective in managing depression by increasing the amount of serotonin available in the brain's synapses. It achieves this through inhibiting its reabsorption into the neurons, thus maintaining elevated levels for extended periods. Serotonin is a crucial neurotransmitter that acts as a messenger within the brain and throughout the body. This chemical plays significant roles in mood regulation, cognition, memory, sleep patterns, hunger, and body temperature among other things. People suffering from depression are believed to have relatively lower levels of serotonin. Therefore by boosting these levels, Lexapro can mitigate the adverse effects of depression helping patients manage their condition and stabilize their moods.
Meanwhile Cymbalta not only increases serotonin but also norepinephrine which helps improve mood disorders like depression or anxiety. Norepinephrine along with serotonin influences attention and behavior significantly which adds another layer to how Cymbalta manages depressive conditions.
What is Cymbalta?
Cymbalta, a brand name for duloxetine, is a serotonin and norepinephrine reuptake inhibitor (SNRI), implying it boosts the levels of serotonin and norepinephrine in the brain by reducing their absorption. Additionally, Cymbalta mildly inhibits the reuptake of dopamine, though to a far lesser extent than its action on serotonin and norepinephrine. First approved by the FDA in 2004, Cymbalta differs from SSRI antidepressants like Lexapro because it influences both serotonin and norepinephrine. This dual action may be beneficial for certain types of depression that do not respond well to SSRIs alone. Its side effect profile is somewhat different from SSRIs; while it can cause common SSRI-associated side effects such as nausea or sexual dysfunction, it also has potential additional side effects related to its influence on norepinephrine such as increased heart rate or blood pressure.
What conditions is Cymbalta approved to treat?
Cymbalta has been approved by the FDA for the management of several conditions, including:
- Major depressive disorder (MDD)
- Generalized anxiety disorder (GAD)
- Diabetic peripheral neuropathic pain
- Fibromyalgia
- Chronic musculoskeletal pain
How does Cymbalta help with these illnesses?
Duloxetine, also known as Cymbalta, is a medication that impacts several neurotransmitters, but most notably serotonin and norepinephrine. These chemicals play vital roles in modulating mood, anxiety, pain perception, and sleep, amongst other functions. Low levels of these neurotransmitters have been associated with depression and anxiety disorders. Cymbalta works by inhibiting the reuptake of these neurotransmitters, effectively increasing their availability in the brain, which can alleviate symptoms of depression, anxiety, and certain pain disorders. Its impact on both serotonin and norepinephrine makes it a SNRI (Serotonin-Norepinephrine Reuptake Inhibitor), as opposed to Lexapro, which is an SSRI (Selective Serotonin Reuptake Inhibitor) and primarily affects serotonin levels. Cymbalta may be a more suitable choice for patients who have not responded adequately to SSRIs like Lexapro, or it may be used in conjunction with other medications to enhance therapeutic effects.
How effective are both Lexapro and Cymbalta?
Both escitalopram (Lexapro) and duloxetine (Cymbalta) are commonly prescribed for the treatment of depression and anxiety disorders, proving successful with their different mechanisms of action. Escitalopram is a selective serotonin reuptake inhibitor (SSRI), while duloxetine falls under a class called serotonin-norepinephrine reuptake inhibitors (SNRIs). Their effectiveness was directly compared in several studies; one notable 2008 clinical trial found that both drugs were comparable in managing symptoms of major depressive disorder, exhibiting similar efficacy and safety profiles.
A review from 2017 demonstrated that escitalopram begins to alleviate symptoms within the first week or two of treatment. Its side effect profile is generally considered favorable among SSRIs, making it well-tolerated across various populations including elderly patients. The same study reports that escitalopram has become widely utilized globally as an antidepressant drug due to its efficiency and tolerability. The typical dose showing optimal efficacy tends to be around 10-20 mg/day, with some evidence suggesting it can reduce suicidal ideation and behavior alongside alleviating depressive symptoms.
On the other hand, a separate 2015 review indicated that duloxetine appears more effective than placebo in treating major depressive disorder with comparably matched efficacy against other common antidepressants. However, unlike bupropion which is usually reserved as a third-line treatment option, duloxetine can often be prescribed earlier on during therapy due to its dual-action nature. Most research about its use involves standalone prescription rather than combined treatments such as co-prescribing along with another SSRI or SNRI thus indicating robust data confirming its standalone potency in handling depression. Due to this unique pharmacology dual-action nature - inhibiting both serotonin and noradrenaline reabsorption - Cymbalta might be ideal for those who did not respond optimally toward SSRIs alone or those needing avoidance from certain adverse effects linked with SSRIs usage such as sexual dysfunction.
Related trials for lexapro and cymbalta
Find Top Clinical Trials
Choose from over 30,000 active clinical trials.
At what dose is Lexapro typically prescribed?
Oral dosages of Lexapro range from 10-20 mg/day, but studies have shown that a daily dose of 10 mg is typically sufficient for treating major depressive disorder in most adults. Adolescents may be started on a lower dose of 5 mg/day. In both populations, the dosage can be increased after a few weeks if there is no response. The maximum dosage that should not be exceeded in any case is 20 mg/day.
On the other hand, oral doses for Cymbalta vary more widely and are dependent on the condition being treated. For depression, dosages usually begin at around 40-60mg per day divided into one or two doses but can be increased to up to 120mg per day based on patient response and tolerance. It's important to note that higher doses do not necessarily lead to better results and may increase side effects.
At what dose is Cymbalta typically prescribed?
Cymbalta therapy typically begins at a dosage of 30–60 mg/day. The dose can then be increased to up to 120 mg/day, divided into two doses spaced approximately 12 hours apart. A maximum dose of 120 mg per day, split into two separate doses of 60 mg and separated by about 12 hours, may be considered if there is no response to treatment at the initial dose after several weeks. As with any medication regimen, it's important that you consult with your healthcare provider before making any changes to ensure optimal safety and efficacy.
What are the most common side effects for Lexapro?
Some of the common side effects that you might experience with Lexapro and Cymbalta include:
- Anxiety
- Nervousness
- Insomnia or trouble sleeping
- Fatigue, sleepiness/drowsiness (somnolence)
- General weakness and fatigue (asthenia)
- Tremor, unintentional trembling or shaking
- Changes in appetite
- Nausea
- Indigestion (dyspepsia), burning sensation, discomfort, or pain in the digestive tract
- Diarrhea
-Dry mouth
-Decreased libido (sexual desire)
-Difficulties with ejaculation; impotence in men.
-Skin rash
-Possible increase in sweating
-Unusual dreams
-Feverish symptoms like those experienced during flu. -Inflammation or soreness in the throat (pharyngitis)
-Inflamed sinuses causing sinusitis symptoms.
-Yawning more often than usual
Remember to contact your healthcare provider if these side effects persist or worsen over time.
Are there any potential serious side effects for Lexapro?
Cymbalta, like many other antidepressants, can have a range of side effects. These may include:
- Increased thoughts about suicide or self-harm, particularly in people under 25 during the initial phases of treatment
- Signs of allergic reaction: hives; difficulty breathing; swelling in your face or throat; severe skin reactions such as fever, sore throat, burning eyes, skin pain followed by a red or purple rash that spreads and causes blistering and peeling
- Changes in vision such as blurred vision and eye pain or swelling
- Cardiovascular changes including fast/pounding heartbeats or fluttering sensations in the chest leading to shortness of breath and potential dizziness (feeling like you might pass out)
- Low sodium levels - symptoms could be headache, confusion, slurred speech accompanied by extreme weakness
- Severe nervous system reactions - very stiff muscles coupled with high fever sweating confusion rapid uneven heartbeats tremors culminating potentially into fainting spells If you experience any symptoms suggestive of serotonin syndrome such as agitation hallucinations fever excessive sweating shivering muscle stiffness twitching loss of coordination nausea vomiting diarrhea please seek immediate medical attention.
What are the most common side effects for Cymbalta?
Cymbalta can potentially lead to several side effects including:
- Dry mouth
- Sleep problems, such as insomnia
- Nausea, constipation, loss of appetite
- Excessive sweating or feeling nervous and restless
- Increased heart rate
- Blurry vision
- Ringing in the ears (tinnitus)
- Muscle pain or aches and joint stiffness
- Headache or dizziness
- Changes in urination frequency
These symptoms might be more prominent during the initial days of treatment but usually decrease over time. If they persist or worsen, consulting with your healthcare provider is recommended. Always remember that Cymbalta has been prescribed because its benefits are judged to outweigh potential risks.
Are there any potential serious side effects for Cymbalta?
While Cymbalta is a commonly prescribed medication with many benefits, it's also important to be aware of potential side effects. Serious adverse reactions can include:
- Signs of an allergic reaction such as hives, difficulty breathing, or swelling in your face or throat
- Alterations in mood and behavior including increased risk of suicidal thoughts especially among teenagers
- Sudden changes in vision like blurred sight or eye pain
- Unusual bleeding or bruising
- Liver problems which might manifest as right-sided abdominal pain, vomiting, loss of appetite, dark urine coloration
- Skin reactions including severe rash and blisters that may lead to peeling
- Problems with urination - either too much or too little.
If you notice any unusual symptoms while taking Cymbalta, reach out to your healthcare provider immediately for guidance.
Contraindications for Lexapro and Cymbalta?
Both Lexapro and Cymbalta, similar to other antidepressant medications, may intensify symptoms of depression in certain individuals. If you observe your depression escalating or an increase in suicidal thoughts or behavior, it is crucial to seek immediate medical assistance.
Neither Lexapro nor Cymbalta should be taken if you are currently taking or have recently been on monoamine oxidase (MAO) inhibitors. It's essential always to inform your healthcare provider about any medication you're consuming; MAOIs will need around 2 weeks with Lexapro and at least 5 days with Cymbalta after the last dose before starting these medications due to potential dangerous interactions. Conversely, a minimum of 14 days should elapse between discontinuation of either Lexapro or Cymbalta and initiation of therapy with a MAOI because of the risk of serotonin syndrome.
How much do Lexapro and Cymbalta cost?
For the brand name versions of these drugs:
- The price of 30 tablets of Lexapro (10 mg) averages around $356, which works out to approximately $11.87/day.
- The price of 30 capsules of Cymbalta (20 mg) is about $249, equating to roughly $8.3/day.
Thus, if you are on a typical dosage for Lexapro (i.e., 10–20mg/day), then brand-name Cymbalta tends to be less expensive on a per-day treatment basis. However, it's important to remember that cost should not be the primary factor in deciding which medication is most suitable for you.
As for their generic versions:
- Escitalopram (generic Lexapro) costs typically range from $0.60 -1.50 per day depending on your dosage and where you purchase them.
- Duloxetine (generic Cymbalta) prices can vary significantly but generally fall within the range of $0.15-$2 per day depending again on dose and point-of-purchase.
Just like their branded counterparts though, generics also offer different pricing levels according to dosages and package sizes available so always check with your healthcare provider or pharmacist before making any decisions based solely off these figures provided here as they may change over time or due to other external factors affecting market conditions.
Popularity of Lexapro and Cymbalta
Escitalopram, also known by brand names such as Lexapro, was estimated to have been prescribed to about 13.5 million people in the US in 2020. It accounts for nearly 20% of SSRI prescriptions and just under 15% of overall antidepressant prescriptions in the country. This is a considerable increase from its prescription numbers since first being approved by the FDA back in August 2002.
Duloxetine, including brand versions such as Cymbalta, had approximately 11 million users in the USA during that same year (2020). In terms of SNRI antidepressants, it accounted for roughly half of all prescriptions – making it one of the most commonly used medications within this class. Duloxetine has seen an increasing trend over time due to its efficacy not just for depression but also generalized anxiety disorder and certain types of chronic pain conditions.
Conclusion
Both Lexapro (escitalopram) and Cymbalta (duloxetine) have extensive records of usage in treating conditions such as depression and anxiety, with numerous clinical studies indicating they are more effective than placebo treatments. In some cases, these medications may be combined, but this requires careful evaluation by a physician due to potential drug interactions. Their mechanisms of action differ; Lexapro primarily impacts serotonin levels while Cymbalta affects both serotonin and norepinephrine levels.
Lexapro is often considered a first-line treatment for depression and generalized anxiety disorder, whereas Cymbalta might also be chosen for its added benefit on chronic pain conditions like fibromyalgia or diabetic neuropathy.
Both drugs are available in generic form which can offer significant cost savings especially for patients paying out-of-pocket. Both Lexapro and Cymbalta require an adjustment period where effects might not be immediately noticeable.
The side effect profiles for both drugs are somewhat similar - they're generally well-tolerated but there could be differences based on individual responses. For instance, while sexual dysfunction can occur with either medication, it's less common with Cymbalta compared to other SSRIs like Lexapro. As always when starting new treatments, patients should closely monitor mood changes or any worsening symptoms that could indicate the need for immediate medical attention.
Other Trials to Consider
Popular Categories
Popular Guides
Learn More About These Treatments
Refrences
- Lee, S.-H., Park, Y., Jin, M. J., Lee, Y. J., & Hahn, S. W. (2017, August 15). Childhood Trauma Associated with Enhanced High Frequency Band Powers and Induced Subjective Inattention of Adults. Frontiers in Behavioral Neuroscience. Frontiers Media SA.http://doi.org/10.3389/fnbeh.2017.00148
- Nierenberg, A. A., Greist, J. H., Mallinckrodt, C. H., Prakash, A., Sambunaris, A., Tollefson, G. D., & Wohlreich, M. M. (2007, January 23). Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study. Current Medical Research and Opinion. Informa UK Limited.http://doi.org/10.1185/030079906x167453
- Hunziker, M. E., Suehs, B. T., Bettinger, T. L., & Crismon, M. L. (2005, August). Duloxetine hydrochloride: A new dual-acting medication for the treatment of major depressive disorder. Clinical Therapeutics. Elsevier BV.http://doi.org/10.1016/j.clinthera.2005.08.010
- Frampton, J. E., & Plosker, G. L. (2007). Duloxetine. CNS Drugs. Springer Science and Business Media LLC.http://doi.org/10.2165/00023210-200721070-00004
- Khan, A., Bose, A., Alexopoulos, G. S., Gommoll, C., Li, D., & Gandhi, C. (2007). Double-Blind Comparison of Escitalopram and Duloxetine in??the??Acute Treatment of Major??Depressive Disorder. Clinical Drug Investigation. Springer Science and Business Media LLC.http://doi.org/10.2165/00044011-200727070-00005
- Chen, Y., Kelton, C. M. L., Jing, Y., Guo, J. J., Li, X., & Patel, N. C. (2008, September). Utilization, price, and spending trends for antidepressants in the US Medicaid program. Research in Social and Administrative Pharmacy. Elsevier BV.http://doi.org/10.1016/j.sapharm.2007.06.019